Table 5. Number (%) of patients with adverse events during the 12-week treatment.
PTV | ATV | |
---|---|---|
(n = 112) | (n = 113) | |
n (%) | n (%) | |
Adverse drug reaction | ||
Myalgia | 1 (0.9) | 2 (1.8) |
Back pain | 2 (1.8) | 3 (2.7) |
Skin rash | 1 (0.9) | 0 (0) |
Sleep disorder | 0 (0) | 0 (0) |
Anxiety | 1 (0.9) | 0 (0) |
Upper airway infection | 4 (3.5) | 6 (5.3) |
Nasopharyngitis | 6 (5.3) | 6 (5.3) |
Cough | 2 (1.8) | 5 (4.4) |